|
1
|
Sterilizing activity of novel TMC207- and PA-824-containing regimens in a murine model of tuberculosis.
|
Antimicrob Agents Chemother
|
2011
|
1.99
|
|
2
|
Sterilizing activities of novel combinations lacking first- and second-line drugs in a murine model of tuberculosis.
|
Antimicrob Agents Chemother
|
2012
|
1.83
|
|
3
|
Dose-ranging comparison of rifampin and rifapentine in two pathologically distinct murine models of tuberculosis.
|
Antimicrob Agents Chemother
|
2012
|
1.63
|
|
4
|
Rifapentine is not more active than rifampin against chronic tuberculosis in guinea pigs.
|
Antimicrob Agents Chemother
|
2012
|
0.98
|
|
5
|
Potent rifamycin-sparing regimen cures guinea pig tuberculosis as rapidly as the standard regimen.
|
Antimicrob Agents Chemother
|
2013
|
0.94
|
|
6
|
A Novel indole compound that inhibits Pseudomonas aeruginosa growth by targeting MreB is a substrate for MexAB-OprM.
|
J Bacteriol
|
2007
|
0.93
|
|
7
|
Activity of the fluoroquinolone DC-159a in the initial and continuation phases of treatment of murine tuberculosis.
|
Antimicrob Agents Chemother
|
2011
|
0.78
|
|
8
|
Reply to "Contradictory results with high-dosage rifamycin in mice and humans".
|
Antimicrob Agents Chemother
|
2013
|
0.75
|